Search All Resources
Alcohol Use Disorder (AUD), Part 1: Understanding, Screening, and Diagnosing AUD | October 7, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #alcohol #aud #brief tools #DSM-5 #Screening
In this presentation, Dr. Price reviews the three-stage addiction cycle, brief tools to screen for unhealthy alcohol use, how to use the DSM-5-TR criteria and determine severity for alcohol use disorder, and identifies when withdrawal risk requires additional assessment.
Date added: 09/24/26
Metabolic Mischief and the Liver | September 23, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #diabetes #dm #liver #MASLD #metabolic #NAFLD #t2d #treatments #weight
In this presentation, Dr. Darling reviews metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease (NAFLD), with a focus on updated nomenclature and diagnostic considerations. Dr. Darling also discusses key risk factors, including type 2 diabetes ...
Date added: 09/15/26
Management of Hepatocellular Carcinoma in Patients with Hepatitis C | September 16, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #cancer #carcinoma #hcc #hcv #hepatitis #hepatocellular #liver #management
In this presentation, Dr. Deming reviews the evaluation and management of hepatocellular carcinoma (HCC) in patients with hepatitis C, including current treatment strategies and multidisciplinary care considerations. She discusses evidence-based approaches to optimize outcomes through timely diagnosis, staging, and individualized ...
Date added: 09/12/26
HCV Screening and Treatment for Pediatrics and Pregnancy | September 2, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #breastfeeding #hcv #pediatrics #pregnancy
In this presentation, Dr. Gabrellas reviews the current hepatitis C screening recommendations in pregnancy and in pediatric patients in the United States, describes the risks and benefits of treating hepatitis C in pregnant and breastfeeding individuals and discusses the current ...
Date added: 09/2/26
HCV 101 | August 27, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv #hcv 101 #primary care #test and treat
In this presentation, Dr. Mera discusses screening, treatment and management of patients with hepatitis C in primary care and provides an opportunity to become part of a learning community.
Date added: 08/27/26
Buprenorphine 101 | August 26, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #buprenorphine #mat #medications for addiction treatment #opioid use disorder #OUD #SUD
In this presentation, Dr. Gregg reviews the fundamentals of buprenorphine therapy for opioid use disorder, including its pharmacology, clinical indications, initiation strategies, and ongoing management. She discusses evidence-based approaches to support the safe and effective use of buprenorphine in clinical ...
Date added: 08/26/26
Treating HCV in Patients with HCC | August 19, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #cancer #carcinoma #hcc #hcv #hepatitis #hepatocellular #liver #management
In this presentation, Dr. Deming reviews the critical, bidirectional relationship between Hepatitis C Virus (HCV) infection and hepatocellular carcinoma (HCC). Participants will examine how achieving a sustained virologic response (SVR) reduces both primary cancer risks and post-treatment recurrence rates. Dr. ...
Date added: 08/19/26
Integration of Pharmacists into Hepatitis C Management | August 5, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #elimination #hcv #hep #hep c #hepatitis #pharmacist
In this presentation, LT Kocher provides an overview of national and local Hepatitis C Virus (HCV) data, and HCV treatment at the Rosebud Indian Health Service clinic. He then describes the steps taken to operationalize pharmacy led efforts to, and ...
Date added: 07/29/26
HCV Diagnosis and Linkage to Care in One Visit: HCV RNA PoC Testing in Action | July 22, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #elimination #hcv #hep #hep c #hepatitis #point of care #rna #Screening
In this presentation, Dr. Mera provides an overview of point-of-care HCV RNA testing and its role in enabling hepatitis C diagnosis and linkage to care within a single visit. He reviews practical implementation strategies and clinical considerations for integrating HCV ...
Date added: 07/10/26
Hepatitis C Elimination in Tribal Health: Expanding Access, Improving Outcomes, and Advancing Population Health | July 1, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #elimination #hcv #hep #hep c #hepatitis #pharm #Screening
In this presentation, Dr. Brownell reviews current evidence-based approaches to hepatitis C screening, evaluation, treatment, and elimination within a tribal healthcare system. She highlights multidisciplinary strategies to expand access to care, the clinical pharmacist's role in hepatitis C management, and interventions that ...
Date added: 07/1/26
